Schrödinger, Inc. (SDGR)
Builds software that simulates molecules to help scientists discover new drugs faster.
$15.37+0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-21.3%
The outlook
Analysts lean bullish on Schrödinger, with an average price target about 34% above the current level. The stock is trading above both its 50- and 200-day moving averages, showing near-term upward momentum. It's positioned in the lower half of its 52-week range, roughly a third of the way up from its yearly low.
What’s behind the score
Analyst consensusBuy — 1.6 avg of 7 analysts
Price trendAbove its 50- & 200-day averages
52-week range37% of the way from its 52-week low to high
Price targetAvg target +34% vs current price
Analyst price target
~12-month · 7 analysts$20.57average target+33.9% vs now
Now $15.37
Low $13.00High $30.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.15B
52-wk high
$23.02
52-wk low
$10.95
50-day avg
$15.01
200-day avg
$15.34
Trailing P/E
—